Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial



(MedPage Today) — NEW ORLEANS — Patients experiencing major heart attacks had a lower risk of serious complications if they received a single injection of the investigational drug zalunfiban at first medical contact, a randomized placebo-controlled…



Source link : https://www.medpagetoday.com/meetingcoverage/aha/118485

Author :

Publish date : 2025-11-12 22:09:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version